Global Granulocyte Macrophage Colony Stimulating Factor Market Research Report 2019-2025

Description

In 2019, the market size of Granulocyte Macrophage Colony Stimulating Factor is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Granulocyte Macrophage Colony Stimulating Factor.

This report studies the global market size of Granulocyte Macrophage Colony Stimulating Factor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Granulocyte Macrophage Colony Stimulating Factor sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd

Market Segment by Product Type
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others

Market Segment by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Granulocyte Macrophage Colony Stimulating Factor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Granulocyte Macrophage Colony Stimulating Factor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Granulocyte Macrophage Colony Stimulating Factor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

TABLE OF CONTENT

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Type (2019-2025)
1.3.2 CG-0070
1.3.3 Gimsilumab
1.3.4 GSK-3196165
1.3.5 Lenzilumab
1.3.6 MGN-1601
1.3.7 Others
1.4 Market Segment by Application
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Share by Application (2019-2025)
1.4.2 Solid Tumor
1.4.3 Lymphoma
1.4.4 Kidney Cancer
1.4.5 Lung Disease
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2014-2025
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2014-2025
2.2 Granulocyte Macrophage Colony Stimulating Factor Growth Rate by Regions
2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions 2014-2019
2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
3.1.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers 2014-2019
3.1.2 Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2014-2019)
3.2.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI)
3.3 Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturers
3.4 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
3.6 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 CG-0070 Sales and Revenue (2014-2019)
4.1.2 Gimsilumab Sales and Revenue (2014-2019)
4.1.3 GSK-3196165 Sales and Revenue (2014-2019)
4.1.4 Lenzilumab Sales and Revenue (2014-2019)
4.1.5 MGN-1601 Sales and Revenue (2014-2019)
4.1.6 Others Sales and Revenue (2014-2019)
4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type
4.3 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type
4.4 Granulocyte Macrophage Colony Stimulating Factor Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application

6 United States
6.1 United States Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
6.2 United States Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
6.3 United States Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

7 European Union
7.1 European Union Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
7.2 European Union Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
7.3 European Union Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

8 China
8.1 China Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
8.2 China Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
8.3 China Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application

9 Rest of World
9.1 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company
9.2 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Type
9.3 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Application
9.4 Rest of World Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Countries
9.4.1 Rest of World Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
9.4.2 Rest of World Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 Aduro BioTech Inc
10.1.1 Aduro BioTech Inc Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.1.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.1.5 Aduro BioTech Inc Recent Development
10.2 Amgen Inc
10.2.1 Amgen Inc Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.2.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.2.5 Amgen Inc Recent Development
10.3 BriaCell Therapeutics Corp
10.3.1 BriaCell Therapeutics Corp Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.3.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.3.5 BriaCell Therapeutics Corp Recent Development
10.4 Cold Genesys Inc
10.4.1 Cold Genesys Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.4.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.4.5 Cold Genesys Inc Recent Development
10.5 GlaxoSmithKline Plc
10.5.1 GlaxoSmithKline Plc Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.5.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.5.5 GlaxoSmithKline Plc Recent Development
10.6 Humanigen Inc
10.6.1 Humanigen Inc Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.6.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.6.5 Humanigen Inc Recent Development
10.7 Mologen AG
10.7.1 Mologen AG Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.7.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.7.5 Mologen AG Recent Development
10.8 Morphotek Inc
10.8.1 Morphotek Inc Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.8.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.8.5 Morphotek Inc Recent Development
10.9 Sillajen Biotherapeutics
10.9.1 Sillajen Biotherapeutics Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.9.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.9.5 Sillajen Biotherapeutics Recent Development
10.10 Takeda Pharmaceutical Co Ltd
10.10.1 Takeda Pharmaceutical Co Ltd Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Granulocyte Macrophage Colony Stimulating Factor
10.10.4 Granulocyte Macrophage Colony Stimulating Factor Product Introduction
10.10.5 Takeda Pharmaceutical Co Ltd Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Granulocyte Macrophage Colony Stimulating Factor Sales Channels
11.2.2 Granulocyte Macrophage Colony Stimulating Factor Distributors
11.3 Granulocyte Macrophage Colony Stimulating Factor Customers

12 Market Forecast
12.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales and Revenue Forecast 2019-2025
12.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type
12.3 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application
12.4 Granulocyte Macrophage Colony Stimulating Factor Forecast by Regions
12.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions 2019-2025
12.4.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample